UBS Raises HF Sinclair Price Target to $126 on Margins

UBS raised its price target for HF Sinclair (NYSE: DINO) to $126 from $105 while maintaining a Buy rating on the stock, pointing to expected margin strength and tailwinds across the company's refining, renewables, and chemical segments, according to an Investing.com report.

HF Sinclair shares trade at $105.41 with a price-to-earnings ratio of 10.1 and a Piotroski Score of 9. The valuation metrics and financial positioning follow the company's second-quarter 2026 financial results, which outpaced analyst expectations.

Second-Quarter Earnings Outperform Estimates

For the second quarter of 2026, HF Sinclair reported adjusted net income of $960 million, or $5.31 per diluted share. That figure topped consensus Wall Street estimates of $4.49 per share, driven by solid performance in the firm's core refining operations.

The independent energy company operates refineries across the Mid-Continent and Rocky Mountain regions, alongside lubricant production and renewable diesel facilities. Refining margins remain a primary driver of cash flow for the enterprise, fluctuating alongside global petroleum product demand and regional crude oil differentials.

Renewable Diesel and Regulatory Tailwinds

Beyond traditional refining, UBS highlighted anticipated margin recovery in HF Sinclair's renewable diesel segment. Margins in this division are projected to lift from below break-even levels to mid-cycle profitability.

This projected rebound stems from regulatory shifts, specifically a revised Renewable Volume Obligation (RVO) and the 100% reallocation of Small Refinery Exemptions (SRE). Under the U.S. Renewable Fuel Standard, the RVO sets annual quotas for renewable fuels blended into the transportation fuel pool, while SRE provisions exempt qualifying small refiners from compliance obligations.

Understanding the Piotroski Score of 9

HF Sinclair's perfect Piotroski Score of 9 indicates underlying financial strength across nine distinct criteria assessing profitability, leverage, liquidity, and operating efficiency. Developed by Stanford accounting professor Joseph Piotroski, the scoring system evaluates balance sheet health to distinguish fundamentally sound value stocks from distressed enterprises.

A score of 9 means a company has achieved top marks across all evaluated metrics, including positive return on assets, improving gross margins, and expanding asset turnover. For equity analysts at firms like UBS, such balance sheet resilience supports capital return programs and provides a buffer against cyclical commodity downturns.